Comparison

AMXI-5001 European Partner

Item no. TMO-T62847-25mg
Manufacturer TargetMol
CASRN 2170491-77-5
Amount 25 mg
Quantity options 25 mg 50 mg
Category
Type Inhibitors
Specific against other
Smiles CCOC(=O)Nc1nc2ccc(cc2[nH]1)-c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping Condition Cool pack
Available
Manufacturer - Targets
Others
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
457.46
Description
AMXI-5001 is a potent, orally active inhibitor of PARP1/2 and microtubule aggregation. AMXI-5001 shows selective anti-tumor cytotoxicity against a wide range of human cancer cells with IC50s well below those of existing clinical PARP1/2 inhibitors and induces complete regression of established tumors, including very large ones.
Pathways
Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close